Literature DB >> 12856642

Prostate biopsy: how many cores are enough?

Joseph C Presti1.   

Abstract

Systematic prostate biopsy has revolutionized our ability to detect prostate cancer. Sextant biopsies were the mainstay of cancer detection since their inception in 1989. Over the past several years more extensive systematic prostate sampling has been introduced and has demonstrated an improved ability to detect prostate cancer. The optimal prostate biopsy scheme should be easy to perform, be able to be done in the clinic without intravenous sedation or general anesthetic, provide a high sensitivity for cancer detection, and have a low complication rate. We review several studies evaluating various biopsy schemes for both initial and repeat biopsy patients and propose an optimal biopsy scheme.

Entities:  

Mesh:

Year:  2003        PMID: 12856642     DOI: 10.1016/s1078-1439(03)00006-1

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  17 in total

1.  Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.

Authors:  Hashim U Ahmed; Oguz Akin; Jonathan A Coleman; Sarah Crane; Mark Emberton; Larry Goldenberg; Hedvig Hricak; Mike W Kattan; John Kurhanewicz; Caroline M Moore; Chris Parker; Thomas J Polascik; Peter Scardino; Nicholas van As; Arnauld Villers
Journal:  BJU Int       Date:  2011-11-11       Impact factor: 5.588

2.  Simulation optimization of PSA-threshold based prostate cancer screening policies.

Authors:  Daniel J Underwood; Jingyu Zhang; Brian T Denton; Nilay D Shah; Brant A Inman
Journal:  Health Care Manag Sci       Date:  2012-12

Review 3.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

Review 4.  Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?

Authors:  Laurence Klotz
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

5.  The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique.

Authors:  Saadettin Yilmaz Eskicorapci; Fuad Guliyev; Ekrem Islamoglu; Ali Ergen; Haluk Ozen
Journal:  Int Urol Nephrol       Date:  2006-06-01       Impact factor: 2.370

Review 6.  Active surveillance for prostate cancer: a review.

Authors:  Laurence Klotz
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

7.  Temporal changes in the clinical approach to diagnosing prostate cancer.

Authors:  William M Hilton; Susan S Padalecki; Donna P Ankerst; Robin J Leach; Ian M Thompson
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

8.  Prostate cancer characterization by optical contrast enhanced photoacoustics.

Authors:  Guan Xu; Ming Qin; Ananya Mukundan; Javed Siddiqui; Marilia Takada; Paulo Vilar-Saavedra; Scott A Tomlins; Raoul Kopelman; Xueding Wang
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-03-15

9.  Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation.

Authors:  Moamen M Amin; Suganthiny Jeyaganth; Nader Fahmy; Louis Bégin; Samuel Aronson; Stephen Jacobson; Simon Tanguay; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

10.  Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy.

Authors:  Katia Ramos Moreira Leite; Luiz Heraldo Camara-Lopes; José Cury; Marcos F Dall'oglio; Adriana Sañudo; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.